Bullous scleroderma-like changes in chronic graft-versus-host disease

Journal of the European Academy of Dermatology and Venereology

Volumn 17, Issue 2, 2003, Pages 200-203

  Moreno, J C ^a   Valverde, F ^a   Martinez, F ^a   Velez A ^a   Torres, A ^a   Fanego, J ^a   Ocana M S ^a  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

Bullous scleroderma; Chronic graft versus host disease

Indexed keywords

ALANINE AMINOTRANSFERASE; CORTICOSTEROID; DEFLAZACORT; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; TACROLIMUS; THALIDOMIDE;

ADOLESCENT; ANEMIA; ARTICLE; BONE MARROW TRANSPLANTATION; BULLOUS SKIN DISEASE; CASE REPORT; CONSULTATION; DISEASE CLASSIFICATION; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN TISSUE; HYPERGLYCEMIA; LEUKOPENIA; LICHENOID; LYMPHATIC LEUKEMIA; MALE; MEDICAL LITERATURE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SCLERODERMA; SKIN BIOPSY; SKIN DEFECT; TREATMENT OUTCOME;

ADOLESCENT; BONE MARROW TRANSPLANTATION; GRAFT VS HOST DISEASE; HUMANS; LEUKEMIA, LYMPHOCYTIC; MALE; SCLERODERMA, LOCALIZED; SKIN DISEASES, VESICULOBULLOUS;

EID: 0037358996     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-3083.2003.00606.x     Document Type: Article

References (24)

1. Yell JA, Wojnarowska F. Bullous skin disease in lupus erythematous. Lupus 1997; 6: 112-121.
2. McCollough ML, Cockerell CJ. Vesiculo-bullous dermatomyositis. Am J Dermatopathol 1998; 20: 170-174.
3. Kobayasi T, Willeberg A, Serup J, Ullman S. Generalized morphea with blister. A report case. Acta Derm Venereol 1990; 70: 454-456.
4. Hymes SR, Farmer ER, Burns WI et al. Bullous sclerodermalike changes in chronic graft-vs-host disease. Arch Dermatol 1985; 121: 1189-1192.
5. Burdick JF, Vogelsang GB, Smith WJ et al. Severe graft-versus-host disease in a liver-transplant recipient. N Engl Med 1988; 318: 689-691.
6. Van der Mast BJ, Hornstra N, Ruigrok MB et al. Transfusion-associated graft-versus-host disease in immunocompetent patients. A self-protective mechanism. Lancet 1994; 343: 753-757.
7. Alain G, Carrier C, Beaumier L et al. In utero acute graft-versus-host disease in a neonate with severe combined immunodeficiency. J Am Acad Dermatol 1993; 29: 862-865.
8. Storb R, Preutice RL, Buckner CD et al. Graft-vs-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical sibling: beneficial effect of protective isolation. N Engl J Med 1983; 308: 302-307.
9. Ammann AJ. New insight into the causes of immunodeficiency disorders. J Am Acad Dermatol 1984; 11: 653-660.
10. Fuji H, Hiketa T, Matsumoto Y et al. Clinical characteristics of chronic cutaneous graft-vs-host disease in Japanese leukemia patients after bone marrow transplantation: Low incidence and mild manifestations of skin lesions. Bone Marrow Transplant 1992; 10: 331-335.
11. Wingard JR, Piantadosi S, Vogelsang GB et al. Predictors of death from chronic graft-vs-host disease after bone marrow transplantation. Blood 1989; 74: 1428-1459.
12. Marrow PA. A case of symmetrical morphea attended with formation of bullae and extensive ulceration. J Cutan Genitourin Dis 1896; 14: 419-427.
13. Garb J, Sims CF. Scleroderma with bullous lesions. Dermatologica 1959; 119: 341-359.
14. Micalizzi C, Parodi A, Rebora A. Generalized bullous morphea. Efficacy of salazopyrin. Clin Exp Dermatol 1996; 21: 246-247.
15. Su WP, Greene SL. Bullous morphea profunda. Am J Dermatopathol 1986; 8: 144-147.
16. Daoud MS, Su WP, Leiferman KM, Perniciaro C. Bullous morphea. clinical, pathologic and immunopathologic evaluation of thirteen cases. J Am Acad Dermatol 1994; 30: 937-943.
17. Saurat JH. Cutaneous manifestations of graft-vs-host disease. Int J Dermatol 1981; 20: 249-256.
18. Lever R, Turbitt M, Mackie R et al. A prospective study of histological changes in the skin of patients receiving bone marrow transplants. Br J Dermatol 1986; 114: 161-170.
19. Synkowski DR, Lobitz WC Jr, Provost TT. Bullous scleroderma. Arch Dermatol 1981; 117: 135-137.
20. Lampert A, Joly P, Thomine E et al. Syndrome sclerodermiforme a type de morphees bulleuses an cours d'un traitment par 5-hydroxytryptophane, carbidopa et flunitrazepan. Ann Dermatol Venereol 1992; 119: 209-211.
21. Wu KH, Dai YS, Lin SC et al. Lichen sclerosus et atrophicus, bullous morphea and systemic lupus erythematosus: a report. J Microbiol Immunol Infect 2000; 33: 53-56.
22. Trattner A, David M, Sandbank M. Bullous morphea: a distinct entity? Am J Dermatopathol 1994; 16: 414-417.
23. Sawamura D, Yaguchi T, Hashimoto I et al. Coexistence of generalized morphea with histological changes in lichen sclerosus et atrophicus and lichen planus. J Dermatol 1998; 25: 409-411.
24. Jampel RM, Farmer ER, Velgelsang GD et al. Puva-therapy for graft-vs-host disease. Arch Dermatol 1991; 127: 1673-1678.